Shoukry, Heba Samy <br/><br/>
Prophylactic supplementation of resveratrol is more effective than its therapeutic use against doxorubicin induced cardiotoxicity.  [electronic resource] 

 -  PloS one  2017 
 - e0181535 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0181535  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Biomarkers--blood<br/>Cardiotoxicity--drug therapy<br/>Creatine Kinase, MB Form--blood<br/>Doxorubicin--toxicity<br/>Drug Administration Schedule<br/>Drug Evaluation, Preclinical<br/>Echocardiography<br/>Heart--diagnostic imaging<br/>Immunohistochemistry<br/>L-Lactate Dehydrogenase--blood<br/>Male<br/>Myocardium--metabolism<br/>NFATC Transcription Factors--metabolism<br/>Protective Agents--administration & dosage<br/>Random Allocation<br/>Rats, Wistar<br/>Resveratrol<br/>Stilbenes--administration & dosage